- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We’re Reading: Expanding Naloxone Access; US Childhood Vaccinations Drop; New COVID-19 Booster Reconsidered
Greater availability of naloxone spray, including over the counter, may reduce opioid overdoses; vaccination rates drop once again for US children; some experts question the necessity of the updated COVID-19 booster shot.
Naloxone Access Could Increase With Policy Shifts
In response to increasing rates of opioid overdoses, particularly fentanyl, federal policy is shifting to make the overdose reversal drug naloxone more accessible to the public, according to CNN. More than 107,000 people died from a drug overdose in the 12-month period ending in August 2022, with fentanyl accounting for two-thirds of those deaths. Annual doses of naloxone dispensed have increased 9-fold in the past 5 years, but opportunities for improvement remain. The FDA plans to meet next month to review the first application for an OTC naloxone nasal spray, but concerns over price and resource waste pose potential issues.
US Childhood Vaccination Rates Dip Again
Vaccination rates during the 2021-2022 school year dipped once again for US kindergarten-age children against diseases such as polio, measles, and diphtheria, according to Reuters. Overall, those receiving state-required vaccinations decreased to about 93% last year, which suggests a decline from the previous school year (94%) and the 2019-2020 school year (95%), according to the CDC. Vaccine experts believe that accessibility and poverty issues must be addressed to bring vaccination rates back to prepandemic levels.
Data Do Not Support COVID-19 Booster Shots for Most, Expert Says
New data suggest the new COVID-19 booster isn’t much more effective in generating neutralizing antibodies than the original vaccine, according to TIME. Further research showed that the bivalent booster did not produce significantly different antibody responses against newer Omicron variants, which accounted for 84% of new infections in the United States in the first week of January. These data lead vaccine expert Paul A. Offit, MD, director of vaccine education and attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, to believe that chasing variants of COVID-19 with boosters may not produce better responses.
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
Lung Transplant Referrals Lag for High-Risk Patients With PAH
July 18th 2025Despite recommendations on early referral for lung transplantation in cases of pulmonary arterial hypertension (PAH), there is a lack of in-depth understanding of this current landscape; in this analysis, clinical parameter data were used to compare outcomes between patients who were and were not referred for lung transplantation.
Read More
AI Meets Medicare: Inside CMS’ WISeR Model With Sanjay Doddamani, MD, MBA
July 17th 2025Sanjay Doddamani, MD, MBA, a former senior advisor to the Center for Medicare and Medicaid Innovation, and internist and cardiologist by training, explains how the Wasteful and Inappropriate Service Reduction (WISeR) Model hopes to work, and addresses concerns about delays and denials from revamped prior authorization processes.
Read More
